ONCOTARTIS

OncoTartis, Inc. is a private biotechnology company established in 2011. Company’s founding IP came from Prof. Andrei Gudkov’s laboratory at Roswell Park Cancer Institute (Buffalo, NY). OncoTartis develops a novel category of anti-cancer drugs directed against tissue-specific targets for a subset of cancers (breast, prostate, ovarian, melanoma and hematological malignancies). Its leading product OT-82 is a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor being developed to treat Acute Myeloid Leukemia (AML). Investigational New Drug application (IND) will be submitted to FDA in the forth quarter of 2017.

#SimilarOrganizations #People #Financial #Website #More

ONCOTARTIS

Industry:

Biometrics Biotechnology Health Care Medical

Founded:

2011-01-01

Address:

Buffalo, New York, United States

Country:

United States

Website Url:

http://www.oncotartis.com

Total Employee:

Status:

Active

Contact:

716.858.3055

Email Addresses:

[email protected]

Total Funding:

6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome AJAX Libraries API Gravatar Profiles WooCommerce Wordpress 4.6